Loading...
*  Respiratory syncytial virus G protein
March 2000). "Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate". Virology. 269 ( ... Respiratory syncytial virus G protein is a protein produced by respiratory syncytial virus. It has been proposed as a target ... Li XQ, Fu ZF, Alvarez R, Henderson C, Tripp RA (January 2006). "Respiratory syncytial virus (RSV) infects neuronal cells and ... Harcourt J, Alvarez R, Jones LP, Henderson C, Anderson LJ, Tripp RA (February 2006). "Respiratory syncytial virus G protein and ...
*  Human respiratory syncytial virus
Esposito, S; Pietro, GD (October 2016). "Respiratory syncytial virus vaccines: an update on those in the immediate pipeline". ... Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of ... "Respiratory Syncytial Virus". Center for Disease Control, Respiratory and Enteric Viruses Branch. October 17, 2008. Retrieved ... Human respiratory syncytial virus is a medium-sized (120-200 nm) enveloped virus that contains a lipoprotein coat and a linear ...
*  Bronchiolitis
Anderson, Larry J.; Graham, Barney S. (2013). Challenges and Opportunities for Respiratory Syncytial Virus Vaccines. Springer ... This is most commonly caused by respiratory syncytial virus (RSV, also known as human pneumovirus). Other viruses which may ... Bronchiolitis is usually the result of infection by respiratory syncytial virus (72% of cases) or human rhinovirus (26% of ... Carbonell-Estrany X, Figueras-Aloy J (2004). "Identifying risk factors for severe respiratory syncytial virus among infants ...
*  Gregory Prince
"VACCINES AND ANTIVIRAL AGENTS - Efficacy and Safety Studies of a Recombinant Chimeric Respiratory Syncytial Virus FG ... Immunoprotective Activity and Safety of a Respiratory Syncytial Virus Vaccine: Mucosal Delivery of Fusion Glycoprotein with a ... "Pulmonary Lesions in Primary Respiratory Syncytial Virus Infection, Reinfection, and Vaccine-Enhanced Disease in the Cotton Rat ... Building on discoveries that Prince made as a doctoral student, VSI pioneered the prevention of respiratory syncytial virus ( ...
*  George Siber
Strategic Partnership With Clearpath To Build Vaccine Portfolio-In-license Vaccine Technology for Respiratory Syncytial Virus ( ... "Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children". The Journal of ... the first Human respiratory syncytial virus immune globulin, and Prevnar, the first Pneumococcal Pneumonia Conjugate. Respigam ... a meningococcal meningitis vaccine, Rotashield, a rotavirus vaccine, and FluMist, a nasal spray influenza vaccine. Since ...
*  List of vaccine topics
T-lymphotropic leukemia vaccine for humans Marburg virus disease vaccine Norovirus vaccine Respiratory syncytial virus vaccine ... vaccine West Nile virus vaccine for humans Zika fever Caries vaccine Ehrlichiosis vaccine Leprosy vaccine Lyme disease vaccine ... encephalitis virus vaccine for humans Ebola vaccine Enterovirus 71 vaccine Epstein-Barr vaccine Hepatitis C vaccine HIV vaccine ... "A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine- ...
*  Novavax
Melinda Gates Foundation to support the development of a vaccine against human respiratory syncytial virus for infants via ... "Novavax RSV vaccine found safe for pregnant women, fetus". Reuters. 2016-09-29. Retrieved 2017-03-28. Herper, Matthew. "Gates ... "Novavax's Ebola vaccine shows promise in early-stage trial". Reuters. 2017-07-21. Retrieved 2017-03-28. "Novavax craters after ... In September 2016 the company announced that a Phase III trial of its RSV vaccine had failed to meet its endpoints, which ...
*  Saint Louis University School of Medicine
... respiratory syncytial virus (RSV) and tuberculosis vaccines. Actually, the Saint Louis School of Medicine is one of only eight ... neurosciences and vaccine research among others. It is a leading center of research in five key areas: cancer, infectious ... and vaccine development". Effective April 1, 2008, Philip O. Alderson, former chairman of the radiology department at Columbia ... vaccine development, cardiac health, and afflictions of the liver. Currently, numerous cutting edge research projects are ...
*  5-lipoxygenase-activating protein
... reduces inflammation in the respiratory syncytial virus-infected mouse eye". Clinical and Vaccine Immunology. 16 (11): 1654-9. ... FLAP is necessary in synthesis of leukotriene, which are lipid mediators of inflammation that is involved in respiratory and ... The structure of FLAP provides a tool for the development of novel therapies for respiratory and cardiovascular diseases and ... Leukotrienes, which need the FLAP protein to be made, have an established pathological role in allergic and respiratory ...
*  AM-679 (FLAP inhibitor)
Reduces Inflammation in the Respiratory Syncytial Virus-Infected Mouse Eye". Clinical and Vaccine Immunology. 16 (11): 1654-9. ...
*  CureVac
... technology platform in the development of a prophylactic vaccine to protect against respiratory syncytial virus (RSV), adding ... Vaccine Prize". "CureVac, Sanofi Paster in 150m-euro-plus vaccines deal". "Boehringer pairs its lung cancer drug with a vaccine ... Dec 2012). "Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection". Nat ... On March 10, 2014, CureVac won a €2 million prize awarded by the European Commission to stimulate new vaccine technologies that ...
*  Natural scientific research in Canada
... pheumococcal infection and respiratory syncytial virus (RSV). Extensive medical research programmes are also undertaken by a ... The laboratory also produced the first trivalent Sabin live oral polio vaccine in 1959, as well as influenza, measles and a ... In 2009, scientists at the NML were the first in the world to decode the genetic sequence for the H1N1 flu virus. Founded in ... Jonas Salk in the US, the laboratories developed a safe inactive vaccine using a new synthetic base, Medium 199. This permitted ...
*  Keith Windschuttle
Human vaccines against diseases including hepatitis B, respiratory syncytial virus and Norwalk virus have been genetically ...
*  Non-specific effect of vaccines
... protects against hospital admissions with infectious diseases and specifically getting ill by respiratory syncytial virus. The ... All live attenuated vaccines studied so far (BCG vaccine, measles vaccine, oral polio vaccine, smallpox vaccine) have been ... All live vaccines studied so far (BCG, measles vaccine, oral polio vaccine (OPV) and smallpox vaccine) have been shown to ... In contrast, inactivated vaccines (diphtheria-tetanus-pertussis vaccine (DTP), hepatitis B vaccine, inactivated polio vaccine) ...
*  Human metapneumovirus
It is the second most common cause after human respiratory syncytial virus (RSV) of lower respiratory infection in young ... A licensed vaccine for humans is still many years distant. The Department of Virology of Erasmus MC, Rotterdam in the ... "Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults". The ... Widmer, Kyle; Griffin, Marie R.; Zhu, Yuwei; Williams, John V.; Talbot, H. Keipp (2014-05-01). "Respiratory syncytial virus- ...
*  Marker vaccine
"Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene ... A marker vaccine allows for immunological differentiation (or segregation) of infected from vaccinated animals, and is also ... In contrast, vaccination with traditional vaccines containing the complete pathogen, either attenuated or inactivated, ... can be used to continuously monitor the efficacy and safety of the vaccine. van Oirschot, J. T.; Rziha, H. J.; Moonen, P. J.; ...
*  Katherine O'Brien
... respiratory syncytial virus; influenza; and Helicobacter pylori. Since 2012 she has served as a member of the World Health ... She has also worked on rotavirus disease, conducting a large phase III trial of rotavirus vaccine among American Indian ... Most recently she has completed a 6-year trial of a monoclonal antibody, motavizumab, against RSV lower and upper respiratory ... This research is critical to understanding pneumococcal vaccine needs and potential efficacy in different regions. The Hib/SP ...
*  George Siber bibliography
Aerosol delivery of respiratory syncytial virus (RSV) antibody to the lungs of cotton rats. Pediatric Research, San Diego, CA ... "Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults". Vaccine. 25 (33): 6164-6. doi:10.1016/j.vaccine ... Aerosol delivery of respiratory syncytial virus (RSV) antibody to the lungs of cotton rats. San Diego, CA, abstract published ... The Respiratory Syncytial Virus Immune Globulin Study Group". The New England Journal of Medicine. 329 (21): 1524-30. doi: ...
*  Genetically modified tomato
... anthrax and respiratory syncytial virus. Korean scientists are looking at using the tomato to express a vaccine against ... "Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine". Proceedings of ... Hilary Koprowski, who was involved in the development of the polio vaccine, led a group of researchers in developing a tomato ... Goyal, R.; Ramachandran, R.; Goyal, P.; Sharma, V. (2007). "Edible vaccines: Current status and future". Indian Journal of ...
*  National Institute of Allergy and Infectious Diseases
... and a preventive therapy for respiratory syncytial virus or RSV (Synagis). Additionally, NIAID partnerships with industry and ... "Vaccine Research Center". National Institute of Allergy and Infectious Diseases. Retrieved 1 November 2016. "Vaccine Research ... Vaccine Research Center (VRC) The Dale and Betty Bumpers Vaccine Research Center is composed of four laboratories and two ... NIAID also was instrumental in the development and licensure of acellular pertussis vaccines, conjugate vaccines for ...
*  Robert M. Chanock
... where he discovered the human respiratory syncytial virus, which is the cause of respiratory tract infections in children each ... as well as an influenza virus vaccine in the form of a nasal spray. Efforts were underway to create a vaccine to deal with ... though efforts to create immunizations for para-influenza viruses and respiratory syncytial virus were unsuccessful. Chanock ... Researchers working with Chanock developed vaccines to prevent adenovirus infection, Hepatitis A and rotavirus, the most common ...
*  Alnylam Pharmaceuticals
... formed alliances with Cubist Pharmaceuticals and Kyowa Hakko Kirin to market a drug targeted at respiratory syncytial virus. In ... In 2011, it partnered with GlaxoSmithKline to develop RNAi technology enhancing vaccine production. The company entered into a ... Weintraub, Arlene (November 1, 2011). "Alnylam and Glaxo Partner on RNAi for Vaccine Production". Xconomy. Retrieved September ... "GSK Taps Alnylam Tech For Faster Vaccine Production". Fierce Pharma. November 3, 2011. Retrieved September 22, 2016. Weintraub ...
*  Texas Biomedical Research Institute
Studying ways of preventing or treating diseases caused by respiratory syncytial virus (RSV), herpes simplex virus, and dengue ... Developing vaccine strategies for Ebola, HIV, Lassa virus, West Nile virus, Japanese encephalitis viruses, and herpes. ... and vaccine development. Developing an animal model to test vaccines to protect people against the Zika virus. In 2015, it was ... Developed vaccines, antibodies and antitoxins for deadly agents of bioterrorism such as Ebola, botulinum neurotoxins, and ...
*  Tawny-bellied cotton rat
Some of the diseases tested on the cotton rat are respiratory syncytial virus, and pulmonary tuberculosis, and HIV type-1. In ... It is affected by many of the same viral and bacterial infections that humans are susceptible to, which helps create vaccines ... "Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus ... the case of HIV type-1, finding an animal with similar antibody response to the virus as humans can prove difficult. A study ...
*  List of MeSH codes (D20)
... pseudorabies vaccines MeSH D20.215.894.899.700 --- rabies vaccines MeSH D20.215.894.899.730 --- respiratory syncytial virus ... herpes simplex virus vaccines MeSH D20.215.894.899.290.500 --- marek disease vaccines MeSH D20.215.894.899.302 --- influenza ... measles vaccine MeSH D20.215.894.899.404.500 --- measles-mumps-rubella vaccine MeSH D20.215.894.899.488 --- mumps vaccine MeSH ... hepatitis a vaccines MeSH D20.215.894.899.955.400 --- hepatitis b vaccines MeSH D20.215.894.899.970 --- yellow fever vaccine ...
*  Atypical pneumonia
Known viral causes of atypical pneumonia include respiratory syncytial virus (RSV), influenza A and B, parainfluenza, ... as the decrease of occult pneumonia after vaccination of children with a pneumococcal vaccine suggests. Infiltration commonly ... "Severe Acute Respiratory Syndrome (SARS) - multi-country outbreak". Archived from the original on 7 December 2008. Retrieved ... Despite general symptoms and problems with the upper respiratory tract (such as high fever, headache, a dry irritating cough ...